Publication | Closed Access

Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers

Breast OncologyMedicineImmunologyPathologyBreast CancerAbundant TumorPoor PrognosisOncologyPrimary Systemic ChemotherapyEndocrine-related Cancer